vs

Side-by-side financial comparison of Realty Income (O) and Solventum (SOLV). Click either name above to swap in a different company.

Solventum is the larger business by last-quarter revenue ($2.0B vs $1.5B, roughly 1.3× Realty Income). Realty Income runs the higher net margin — 20.7% vs 0.6%, a 20.1% gap on every dollar of revenue. On growth, Realty Income posted the faster year-over-year revenue change (12.2% vs -3.0%). Over the past eight quarters, Realty Income's revenue compounded faster (7.5% CAGR vs -1.8%).

Realty Income Corporation is a real estate investment trust that invests in free-standing, single-tenant commercial properties in the United States, the United Kingdom, and six other countries in Europe. These properties are subject to NNN Leases. The company is organized in Maryland with its headquarters in San Diego, California.

Solventum Corporation is an American health care company that was spun off from 3M on April 1, 2024.

O vs SOLV — Head-to-Head

Bigger by revenue
SOLV
SOLV
1.3× larger
SOLV
$2.0B
$1.5B
O
Growing faster (revenue YoY)
O
O
+15.2% gap
O
12.2%
-3.0%
SOLV
Higher net margin
O
O
20.1% more per $
O
20.7%
0.6%
SOLV
Faster 2-yr revenue CAGR
O
O
Annualised
O
7.5%
-1.8%
SOLV

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
O
O
SOLV
SOLV
Revenue
$1.5B
$2.0B
Net Profit
$320.9M
$13.0M
Gross Margin
54.7%
Operating Margin
4.0%
Net Margin
20.7%
0.6%
Revenue YoY
12.2%
-3.0%
Net Profit YoY
27.6%
EPS (diluted)
$0.33
$0.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
O
O
SOLV
SOLV
Q1 26
$1.5B
$2.0B
Q4 25
$1.5B
$2.0B
Q3 25
$1.5B
$2.1B
Q2 25
$1.4B
$2.2B
Q1 25
$1.4B
$2.1B
Q4 24
$1.3B
$2.1B
Q3 24
$1.3B
$2.1B
Q2 24
$1.3B
$2.1B
Net Profit
O
O
SOLV
SOLV
Q1 26
$320.9M
$13.0M
Q4 25
$296.1M
$63.0M
Q3 25
$315.8M
$1.3B
Q2 25
$196.9M
$90.0M
Q1 25
$249.8M
$137.0M
Q4 24
$199.6M
$31.0M
Q3 24
$269.5M
$122.0M
Q2 24
$259.4M
$89.0M
Gross Margin
O
O
SOLV
SOLV
Q1 26
54.7%
Q4 25
51.4%
Q3 25
54.2%
Q2 25
54.4%
Q1 25
53.8%
Q4 24
53.9%
Q3 24
56.0%
Q2 24
54.6%
Operating Margin
O
O
SOLV
SOLV
Q1 26
4.0%
Q4 25
21.7%
6.3%
Q3 25
23.2%
80.6%
Q2 25
15.8%
9.9%
Q1 25
19.3%
7.3%
Q4 24
16.5%
6.6%
Q3 24
21.5%
13.2%
Q2 24
20.7%
11.7%
Net Margin
O
O
SOLV
SOLV
Q1 26
20.7%
0.6%
Q4 25
19.9%
3.2%
Q3 25
21.5%
60.4%
Q2 25
14.0%
4.2%
Q1 25
18.1%
6.6%
Q4 24
14.9%
1.5%
Q3 24
20.2%
5.9%
Q2 24
19.4%
4.3%
EPS (diluted)
O
O
SOLV
SOLV
Q1 26
$0.33
$0.07
Q4 25
$0.32
$0.37
Q3 25
$0.35
$7.22
Q2 25
$0.22
$0.51
Q1 25
$0.28
$0.78
Q4 24
$0.23
$0.18
Q3 24
$0.30
$0.70
Q2 24
$0.29
$0.51

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
O
O
SOLV
SOLV
Cash + ST InvestmentsLiquidity on hand
$388.4M
$561.0M
Total DebtLower is stronger
$4.6B
Stockholders' EquityBook value
$39.1B
$5.0B
Total Assets
$74.6B
$14.1B
Debt / EquityLower = less leverage
0.92×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
O
O
SOLV
SOLV
Q1 26
$388.4M
$561.0M
Q4 25
$434.8M
$878.0M
Q3 25
$417.2M
$1.6B
Q2 25
$800.4M
$492.0M
Q1 25
$319.0M
$534.0M
Q4 24
$445.0M
$762.0M
Q3 24
$397.0M
$772.0M
Q2 24
$442.8M
$897.0M
Total Debt
O
O
SOLV
SOLV
Q1 26
$4.6B
Q4 25
$5.0B
Q3 25
$5.1B
Q2 25
$7.8B
Q1 25
$7.9B
Q4 24
$8.0B
Q3 24
$8.1B
Q2 24
$8.3B
Stockholders' Equity
O
O
SOLV
SOLV
Q1 26
$39.1B
$5.0B
Q4 25
$39.4B
$5.0B
Q3 25
$39.1B
$5.0B
Q2 25
$39.2B
$3.6B
Q1 25
$39.0B
$3.3B
Q4 24
$38.8B
$3.0B
Q3 24
$38.5B
$3.2B
Q2 24
$38.6B
$2.9B
Total Assets
O
O
SOLV
SOLV
Q1 26
$74.6B
$14.1B
Q4 25
$72.8B
$14.3B
Q3 25
$71.3B
$14.0B
Q2 25
$71.4B
$15.1B
Q1 25
$69.8B
$14.5B
Q4 24
$68.8B
$14.5B
Q3 24
$68.5B
$14.7B
Q2 24
$68.1B
$14.6B
Debt / Equity
O
O
SOLV
SOLV
Q1 26
0.92×
Q4 25
1.00×
Q3 25
1.03×
Q2 25
2.14×
Q1 25
2.43×
Q4 24
2.71×
Q3 24
2.54×
Q2 24
2.90×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
O
O
SOLV
SOLV
Operating Cash FlowLast quarter
$874.5M
Free Cash FlowOCF − Capex
$-273.0M
FCF MarginFCF / Revenue
-13.6%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
2.72×
TTM Free Cash FlowTrailing 4 quarters
$-203.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
O
O
SOLV
SOLV
Q1 26
$874.5M
Q4 25
$1.2B
$95.0M
Q3 25
$943.1M
$76.0M
Q2 25
$1.1B
$169.0M
Q1 25
$787.5M
$29.0M
Q4 24
$972.0M
$219.0M
Q3 24
$841.5M
$169.0M
Q2 24
$981.2M
$355.0M
Free Cash Flow
O
O
SOLV
SOLV
Q1 26
$-273.0M
Q4 25
$1.2B
$32.0M
Q3 25
$909.9M
$-21.0M
Q2 25
$1.0B
$59.0M
Q1 25
$764.6M
$-80.0M
Q4 24
$935.8M
$92.0M
Q3 24
$807.9M
$76.0M
Q2 24
$939.2M
$297.0M
FCF Margin
O
O
SOLV
SOLV
Q1 26
-13.6%
Q4 25
77.6%
1.6%
Q3 25
61.9%
-1.0%
Q2 25
73.3%
2.7%
Q1 25
55.4%
-3.9%
Q4 24
69.8%
4.4%
Q3 24
60.7%
3.7%
Q2 24
70.1%
14.3%
Capex Intensity
O
O
SOLV
SOLV
Q1 26
0.0%
Q4 25
3.3%
3.2%
Q3 25
2.3%
4.6%
Q2 25
1.9%
5.1%
Q1 25
1.7%
5.3%
Q4 24
2.7%
6.1%
Q3 24
2.5%
4.5%
Q2 24
3.1%
2.8%
Cash Conversion
O
O
SOLV
SOLV
Q1 26
2.72×
Q4 25
4.06×
1.51×
Q3 25
2.99×
0.06×
Q2 25
5.39×
1.88×
Q1 25
3.15×
0.21×
Q4 24
4.87×
7.06×
Q3 24
3.12×
1.39×
Q2 24
3.78×
3.99×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

O
O

Rental (including reimbursements) (1)$1.4B93%
Other$107.9M7%

SOLV
SOLV

Infection Prevention and Surgical Solutions$737.0M37%
Advanced Wound Care$497.0M25%
Dental Solutions$354.0M18%
Health Information Systems$342.0M17%
All Other 4$76.0M4%

Related Comparisons